Thus, TCF7-positive T cells are tumor-specific CD8 cells that express PD-1 and other exhaustion-associated markers as a result of chronic activation but are able to functionally recover in response to PD-1 inhibition. The gene discussed is CD8A; the disease is neoplasm.